Getting Personal With Advanced BTC: Insights on Personalizing Upfront and Sequential Care With Immunotherapy and Targeted Agents
Getting Personal With Advanced BTC: Insights on Personalizing Upfront and Sequential Care With Immunotherapy and Targeted Agents is organized by PVI, PeerView Institute for Medical Education.
Activity Release Date: January 21, 2023
Activity Expiration Date: February 20, 2024
Activity Description:
New science continues to support a diverse management model for advanced biliary tract cancers (BTCs), including immune-based and targeted platforms, culminating to the first meaningful advancements in frontline therapy for advanced/metastatic BTC in over a decade. Collectively these clinical trends have expanded the use of individualized management strategies, leading to enhanced clinical outcomes for patients with advanced BTC.
In this activity, based on a recent live symposium, expert panelists provide data and practical guidance on the current status of care in BTC and new developments related to the use of novel and emerging immunotherapies and targeted options (eg, PD-1 and PD-L1 inhibitors, FGFR, IDH, TRK, and HER2-directed agents). Case presentations explore next-generation care for today’s patients with BTC using personalized upfront and sequential treatment management models. Don’t miss this chance to get personal with advanced BTC!
Educational Objectives:
Upon completion of this activity, participants should be better able to:
• Summarize the latest clinical evidence supporting the use of immunotherapy and targeted platforms for patients with advanced BTCs
• Develop personalized management plans for patients with advanced BTCs based on up-to-date clinical evidence on novel immunotherapeutic and targeted approaches, expert recommendations, comorbidities, and other factors at baseline
• Manage unique safety considerations associated with the use of novel targeted and immunotherapy options for BTCs.
